TORRENT PHARMACEUTICALS L vs ZIM LABORATORIES LIMITED
A side-by-side comparison of TORRENT PHARMACEUTICALS L (TORNTPHARM) and ZIM LABORATORIES LIMITED (ZIMLAB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, TORRENT PHARMACEUTICALS L leads TORNTPHARM vs ZIMLAB on 12 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
Valuation
How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 57.8%"]
- − ["Stock is trading at 19.8 times its book value", "The company has delivered a poor sales growth of 11.8% over past five years.", "Company might be capitalizing the interest cost"]
- + ["Company's working capital requirements have reduced from 52.8 days to 41.0 days"]
- − ["Though the company is reporting repeated profits, it is not paying out dividend", "Company has low interest coverage ratio.", "Promoter holding has decreased over last quarter: -2.91%", "The company has delivered a poor sales growth of 4.03% over past five years.", "Promoter holding is low: 30.4%", "Company has a low return on equity of 4.54% over last 3 years.", "Earnings include an other income of Rs.11.4 Cr."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.